LifeStance Health Price to Sales Ratio 2020-2025 | LFST
Historical PS ratio values for LifeStance Health (LFST) over the last 10 years. The current P/S ratio for LifeStance Health as of February 10, 2026 is .
| LifeStance Health P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-02-10 | 6.95 | 1.96 | |
| 2025-09-30 | 5.50 | $3.54 | 1.55 |
| 2025-06-30 | 5.17 | $3.43 | 1.51 |
| 2025-03-31 | 6.66 | $3.36 | 1.98 |
| 2024-12-31 | 7.37 | $3.30 | 2.23 |
| 2024-09-30 | 7.00 | $3.21 | 2.18 |
| 2024-06-30 | 4.91 | $3.09 | 1.59 |
| 2024-03-31 | 6.17 | $2.98 | 2.07 |
| 2023-12-31 | 7.83 | $2.88 | 2.71 |
| 2023-09-30 | 6.87 | $2.77 | 2.48 |
| 2023-06-30 | 9.13 | $2.67 | 3.42 |
| 2023-03-31 | 7.43 | $2.55 | 2.92 |
| 2022-12-31 | 4.94 | $2.43 | 2.04 |
| 2022-09-30 | 6.62 | $2.36 | 2.81 |
| 2022-06-30 | 5.56 | $2.26 | 2.46 |
| 2022-03-31 | 10.11 | $2.18 | 4.64 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.704B | $1.251B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $33.614B | 16.95 |
| Quest Diagnostics (DGX) | United States | $22.844B | 20.85 |
| Elanco Animal Health (ELAN) | United States | $12.725B | 26.68 |
| Encompass Health (EHC) | United States | $10.967B | 19.96 |
| DaVita (DVA) | United States | $9.833B | 12.82 |
| Chemed (CHE) | United States | $6.402B | 22.49 |
| RadNet (RDNT) | United States | $5.406B | 184.40 |
| Option Care Health (OPCH) | United States | $5.262B | 22.40 |
| Addus HomeCare (ADUS) | United States | $1.999B | 20.64 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.642B | 20.68 |
| U.S Physical Therapy (USPH) | United States | $1.299B | 32.85 |
| Astrana Health (ASTH) | United States | $1.085B | 101.42 |
| Pennant (PNTG) | United States | $1.071B | 35.60 |
| Daxor (DXR) | United States | $0.061B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.038B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |